Evidence map›Paper›PMID 31566935›Full record

ReviewBrain and behavior2019

Clinical applications of transcranial magnetic stimulation in bipolar disorder.

Alexandra K Gold, Ana Claudia Ornelas, Patricia Cirillo, Marco Antonio Caldieraro, Antonio Egidio Nardi, Andrew A Nierenberg, Gustavo Kinrys

Open access · goldAbstract readReview
In one paragraph

Review in Brain and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Functional neuroanatomy of mania.Translational psychiatry · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Alexandra K GoldDepartment of Psychological and Brain Sciences, Boston University, Boston, MA, USA.ORCID 0000-0002-5090-5153
Ana Claudia OrnelasOutpatient Resistant Depression Clinic and Laboratory of Panic & Respiration, Institute of Psychiatry, Rio de Janeiro, Brazil.
Patricia CirilloOutpatient Resistant Depression Clinic and Laboratory of Panic & Respiration, Institute of Psychiatry, Rio de Janeiro, Brazil.
Marco Antonio CaldieraroServiço de Psiquiatria, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
Antonio Egidio NardiOutpatient Resistant Depression Clinic and Laboratory of Panic & Respiration, Institute of Psychiatry, Rio de Janeiro, Brazil.ORCID 0000-0002-2152-4669
Andrew A NierenbergDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Gustavo KinrysDepartment of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-5845-8327
Harvard University · USBoston University · USUniversidade Federal do Rio Grande do Sul · BR

Funding

Impaired Risk Avoidance in Bipolar Disorder and Substance Use DisordersF31MH116557 · NIMH · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GOLD, ALEXANDRA KATE · 2018 to 2021
$100k
NIMH NIH HHS F31 MH116557
6 · The paper itself

Abstract

backgroundMany patients with bipolar disorder (BD) fail to experience benefit following traditional pharmacotherapy, necessitating alternative treatment options that will enable such patients to achieve remission. Transcranial magnetic stimulation (TMS) is a relatively new, noninvasive neuromodulation technique that involves the application of magnetic pulses on hyperactive or hypoactive cortical brain areas. We evaluated the existing literature on TMS as a treatment for BD across varied mood states.

methodsWe searched PubMed up to October 2018 for original data articles published in English that evaluated outcomes in a bipolar sample across depressive, manic, mixed, and maintenance phases of BD.

resultsClinical trials of TMS for BD particularly suggest the potential of repetitive TMS for reducing depressive symptoms. Studies of TMS for mania have yielded more mixed findings. Few studies have evaluated TMS in other phases of the bipolar illness. TMS is generally associated with mild side effects though, in a few studies, it has been shown to contribute to a manic switch in previously depressed bipolar patients.

conclusionsTranscranial magnetic stimulation is a promising approach for treating patients with BD who have failed to respond to pharmacological or psychosocial treatment. Future research should more clearly elucidate which TMS protocols may be most effective for a given bipolar patient.

Indexed as

Bipolar DisorderHumansTranscranial Magnetic StimulationTreatment Outcomebipolar disorderneuromodulationtranscranial magnetic stimulation

Identifiers

PMID31566935
PMCPMC6790310
OpenAlexW2977354488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.